Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Med Mycol ; 39(1): 151-4, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11270405

ABSTRACT

Cryptococcus neoformans is an excellent model system for studies on the molecular pathogenesis of fungal infections. There is only one dominant selectable market that can be used in the transformation of this organism, and we wanted to develop another. We found that various strains of C. neoformans are very sensitive to the aminoglycoside antibiotic nourseothricin, and that spontaneous resistance to this drug must be an extremely rare event. Resistance to nourseothricin is conferred by the product of the nourseothricin acetyltransferase gene (nat1) from Streptomyces noursei. In order to express this gene in C. neoformans, we created a fusion construct by driving expression of natl with the promoter sequence from a C. neoformans actin gene. Biolistic transformation of the serotype A C. neoformans strain H99 and the serotype D strain JEC21 with this construct resulted in transformation efficiencies of approximately 1,000 transformants microg(-1) of DNA and 20 transformants microg(-1) of DNA, respectively. Southern blots were performed using DNA from some of the H99 transformants, and this confirmed that all of the resistant isolates had the construct integrated in a random fashion within the genome. There was no cross-resistance of the nourseothricin-resistant transformants to hygromycin B, which is the other antibiotic used as a dominant selection marker in C. neoformans. The development of nourseothricin resistance as a second dominant selectable market will be helpful in future molecular studies on this important pathogenic fungus.


Subject(s)
Cryptococcus neoformans/genetics , Genetic Markers , Streptothricins/pharmacology , Acetyltransferases/genetics , Actins/biosynthesis , Cryptococcus neoformans/drug effects , Drug Resistance, Microbial/genetics , Genes, Bacterial , Genetic Complementation Test , Hygromycin B/pharmacology , Recombinant Fusion Proteins/biosynthesis , Transformation, Bacterial
2.
Mol Microbiol ; 39(1): 166-75, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11123698

ABSTRACT

The human pathogenic fungus Cryptococcus neoformans secretes a phospholipase enzyme that demonstrates phospholipase B (PLB), lysophospholipase hydrolase and lysophospholipase transacylase activities. This enzyme has been postulated to be a cryptococcal virulence factor. We cloned a phospholipase-encoding gene (PLB1) from C. neoformans and constructed plb1 mutants using targeted gene disruption. All three enzyme activities were markedly reduced in the mutants compared with the wild-type parent. The plb1 strains did not have any defects in the known cryptococcal virulence phenotypes of growth at 37 degrees C, capsule formation, laccase activity and urease activity. The plb1 strains were reconstituted using the wild-type locus and this resulted in restoration of all extracellular PLB activities. In vivo testing demonstrated that the plb1 strain was significantly less virulent than the control strains in both the mouse inhalational model and the rabbit meningitis model. We also found that the plb1 strain exhibited a growth defect in a macrophage-like cell line. These data demonstrate that secretory phospholipase is a virulence factor for C. neoformans.


Subject(s)
Cryptococcus neoformans/pathogenicity , Phospholipases/metabolism , Acyltransferases/metabolism , Animals , Cells, Cultured , Cloning, Molecular , Cryptococcosis/mortality , Cryptococcus neoformans/genetics , Female , Genes, Fungal , Lysophospholipase/metabolism , Macrophages/microbiology , Meningitis, Cryptococcal/mortality , Mice , Multienzyme Complexes/metabolism , Mutagenesis, Insertional , Mutation , Phospholipases/genetics , Rabbits
3.
Infect Immun ; 68(5): 2845-53, 2000 May.
Article in English | MEDLINE | ID: mdl-10768981

ABSTRACT

The ability of Cryptococcus neoformans to synthesize polymerized melanin in vitro has been associated with virulence, but it is unclear whether this fungus synthesizes polymerized melanin during infection. To study this question, we used two approaches: one involved the generation of monoclonal antibodies (MAbs) to melanin for use in immunohistochemical studies of C. neoformans-infected rodents, and the other sought to isolate fungal melanin from infected tissues. Digestion of in vitro-melanized C. neoformans cells with proteases, denaturant, and hot concentrated acid yields melanin particles that retain the shape of fungal cells and are therefore called melanin ghosts. BALB/c mice were immunized with melanin ghosts, and two immunoglobulin M MAbs to melanin were generated from the spleen of one mouse. Immunofluorescence analyses of lung and brain tissues of rodents infected with wild-type melanin-producing (Mel(+)) C. neoformans strains demonstrated binding of the MAbs to the fungal cell wall. No binding was observed when infections were performed with mutant albino (Mel(-)) C. neoformans strains. Particles with striking similarity to melanin ghosts were recovered after digestion of lung and brain tissues from Mel(+) C. neoformans-infected rodents and were reactive with the MAbs to melanin. No particles were recovered from tissues infected with Mel(-) C. neoformans. A Mel(+) C. neoformans strain grown on lung or brain homogenate agar became lightly pigmented and also yielded particles similar to melanin ghosts upon digestion, providing additional evidence that lung and brain tissues contain substrate for C. neoformans melanization. These results demonstrate that C. neoformans synthesizes polymerized melanin during infection, which has important implications for pathogenesis and antifungal drug development.


Subject(s)
Cryptococcosis/metabolism , Melanins/biosynthesis , Polymers , Animals , Antibodies, Monoclonal/biosynthesis , Antibodies, Monoclonal/immunology , Cryptococcosis/pathology , Cryptococcus neoformans/metabolism , Female , Fluorescent Antibody Technique , Immunohistochemistry , Melanins/immunology , Mice , Mice, Inbred BALB C , Reproducibility of Results
SELECTION OF CITATIONS
SEARCH DETAIL
...